Immunocore Holdings (IMCR) Non-Current Debt (2020 - 2026)

Immunocore Holdings has reported Non-Current Debt for 7 years, with the latest figure at $393.7 million in Q1 2026.

• Quarterly Non-Current Debt rose 0.54% year-over-year to $393.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $393.7 million (up 0.54% YoY) and the FY2025 annual result came in at $393.1 million, up 0.54% from the prior year.
• Non-Current Debt was little changed at $393.7 million in Q1 2026 per IMCR's latest filing, from $393.1 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $438.1 million in Q2 2024 and troughed at $46.3 million in Q4 2022.
• A 5-year average of $293.4 million and a median of $391.5 million in 2025 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2024 and 2025: Non-Current Debt jumped 843.3% in 2024, then retreated 10.52% in 2025.
• Over 5 years, Non-Current Debt stood at $46.3 million in 2022, then advanced by 3.63% to $48.0 million in 2023, then jumped by 714.42% to $391.0 million in 2024, then rose by 0.54% to $393.1 million in 2025, then advanced by 0.14% to $393.7 million in 2026.
• According to Business Quant data, Non-Current Debt over the past three periods registered $393.7 million, $393.1 million, and $392.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.